Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
The current Abbott(ABT) stock price is $125.08, with a market capitalization of 217.39B. The stock trades at a price-to-earnings (P/E) ratio of 15.69 and offers a dividend yield of 1.9%.
On 2025-12-07, Abbott(ABT) stock traded between a low of $124.64 and a high of $126.05. Shares are currently priced at $125.08, which is +0.4% above the low and -0.8% below the high.
The Abbott(ABT)'s current trading volume is 4.33M, compared to an average daily volume of 6.53M.
During the past year, Abbott(ABT) stock moved between $110.86 at its lowest and $141.23 at its peak.
During the past year, Abbott(ABT) stock moved between $110.86 at its lowest and $141.23 at its peak.
ABT News
The U.S. Food and Drug Administration (FDA) in December issued a safety alert urging people with diabetes to stop using select glucose sensors made by Abbott La...
Wondering if Abbott Laboratories is still worth buying after its long run as a healthcare blue chip, or if most of the upside is already priced in? Despite a m...
The Food and Drug Administration has cautioned people to stop using FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitor sensors after manufacturer Abbo...
Analyst ratings
68%
of 31 ratingsMore ABT News
Don't bet against it. One effective way to earn solid, long-term returns is to invest in dividend-paying stocks since reinvesting the payout can help boost sto...
Anyone interested in Abbott Laboratories ( ) should probably be aware that a company insider, Eric Shroff, recently divested US$203k worth of shares in the comp...
Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the nea...
Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor m...
Key Points Abbott Laboratories is acquiring Exact Sciences, in a move that will help bolster its diagnostics business. Abbott should expand the reach of Exact...